Cargando…
Clinical Laboratory Results as Prognosis Marker in Advanced Stage Non-small Cell Lung Cancer (NSCLC) in Indonesia
Background: Lung cancer is the most common cause of cancer-related death among men in the world. Given the very high mortality caused by lung cancer, a biological marker to determine a more sensitive therapy among non-small cell lung cancer (NSCLC) patients is needed. This study aims to demonstrate...
Autores principales: | Hanafi, Arif R, Jayusman, Achmad M, Sutandyo, Noorwati, Kurniawati, Sri, Setiawan, Lyana, Diandra, Alyssa, Hidayat, Kusmantoro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585362/ https://www.ncbi.nlm.nih.gov/pubmed/36304376 http://dx.doi.org/10.7759/cureus.29386 |
Ejemplares similares
-
Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
por: Sutandyo, Noorwati, et al.
Publicado: (2023) -
Repurposing FIB-4 index as a predictor of mortality in patients with hematological malignancies and COVID-19
por: Sutandyo, Noorwati, et al.
Publicado: (2021) -
Comparison of Effectiveness of Gefitinib, Erlotinib, and Afatinib in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutation Positive in Indonesian Population
por: SUTANDYO, Noorwati, et al.
Publicado: (2019) -
Association of Body Composition and Handgrip Strength with Interleukin-6 (IL-6) and Vitamin D Level in Cancer Patients
por: Sutandyo, Noorwati, et al.
Publicado: (2023) -
Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia
por: HANAFI, Arif R, et al.
Publicado: (2020)